[Prophylaxis and treatment of fungal infections in oncohematological patients].
出版信息
Rev Esp Quimioter. 2002 Dec;15(4):387-401.
PMID:12607556
Abstract
摘要
相似文献
1
[Prophylaxis and treatment of fungal infections in oncohematological patients].
Rev Esp Quimioter. 2002 Dec;15(4):387-401.
2
Fungal infections in patients with cancer.
Pharmacotherapy. 1990;10(6 ( Pt 3)):164S-169S.
3
Fungal infection and fever of unknown origin in neutropenic patients.
Am J Med. 1986 May 30;80(5C):112-9.
4
[Treatment of fungal infections in patients with hematologic neoplasia].
Med Clin (Barc). 2009 Apr 11;132(13):507-21. doi: 10.1016/j.medcli.2009.01.008. Epub 2009 Apr 5.
5
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
J Antimicrob Chemother. 2009 May;63 Suppl 1:i14-5. doi: 10.1093/jac/dkp075.
6
[Prophylaxis of fungal infections in haematological patients: pro].
Dtsch Med Wochenschr. 2010 Sep;135(38):1870. doi: 10.1055/s-0030-1263329. Epub 2010 Sep 14.
7
[Antimicrobial prophylaxis and therapy in neutropenia].
Mycoses. 2003;46 Suppl 2:21-32.
8
[Malignant blood diseases and fungal infection: what does mycology provide in the year 2001?].
Enferm Infecc Microbiol Clin. 2001 Aug-Sep;19(7):293-5. doi: 10.1016/s0213-005x(01)72648-1.
9
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
J Antimicrob Chemother. 2006 Feb;57(2):317-25. doi: 10.1093/jac/dki440. Epub 2005 Dec 8.
10
Persistent fever in patients with neutropenia.
N Engl J Med. 2002 Jan 24;346(4):222-4. doi: 10.1056/NEJM200201243460402.
引用本文的文献
1
[Anti-fungal drugs. Current status and guidelines for their administration].
Clin Transl Oncol. 2005 Oct;7(9):377-88. doi: 10.1007/BF02716583.
2
Caspofungin: a review of its use in the treatment of fungal infections.
Drugs. 2005;65(14):2049-68. doi: 10.2165/00003495-200565140-00009.
Zotero 插件